Tratopedia
繁中
Settings

Text size

Language

Theme

High contrast

Version

v1.230.2

The release this page was built from. It is what the service worker caches under.

Reverse transcriptase · Central dogma · Research briefScience, 16 April 2026, record to August 2026

Stanford, the Alex Gao lab · bacterial anti-phage defence

A Way of Making DNA in Which the Protein Is the Blueprint

A team led by Alex Gao at Stanford has described a bacterial defence enzyme, Drt3b, that builds DNA using the arrangement of amino acids in its own active site as the template — not RNA. The finding is peer-reviewed, published in Science and confirmed by a cryo-EM structure of the complex. Drt3b manufactures one fixed, repeating sequence; whether that counts as a challenge to the central dogma of molecular biology is disputed among the biologists who have examined it.

  • 2 RTDRT3 pairs a conventional Drt3a with an unconventional Drt3b
  • 2.6 Åresolution of the cryo-EM structure of the Drt3a:Drt3b:ncRNA complex
  • 6:6:6stoichiometry of that resolved complex
  • 103days from the original paper to a confirmed defence mechanism

How Firmly Each Part Stands Confirmed by peer review, and confirmed but not readable at its own source.

How firmWhatWho says so
ConfirmedDeng, Lee, Armijo, Wang and Gao describe the Drt3a/Drt3b structure and mechanism, resolved by cryo-EM to 2.6 ÅScience, peer-reviewed and PubMed-indexed (PMID 41990131)
ConfirmedDRT3 is cytotoxic in bacterial cells lacking the host recombination complex RecBCD; the phage-encoded RecBCD inhibitor Gam triggers DRT3's abortive-infection responseCell, peer-reviewed and PubMed-indexed (PMID 42520802)
ConfirmedRichard Stone's news article reporting the finding, quoting Gao, Millman, Kranzusch and Bernheim, was published in Science on 16 April 2026Corroborated via an EBSCO database record and a Crossref DOI record, both read directly; the article's own page returned a bot-detection wall (HTTP 403) in this session
Confirmed, but not verifiable hereThe quotations attributed to Gao, Millman, Kranzusch and Bernheim, as Stone's article reports themGao’s corroborated by independent secondary outlets (ScienceAlert, AOL/Popular Mechanics) that attribute the same words to the same name; Millman’s, Kranzusch’s and Bernheim’s only by search extracts that do the same; Stone’s own page could not be read directly in this session

Every Publication With a Date Ten papers and reports, over sixteen weeks

  1. 16 Apr 2026Science publishes Deng, Lee, Armijo, Wang and Gao's paper on DRT3, and Richard Stone's accompanying news article.
  2. 21 Apr 2026ScienceAlert and the CRISPeR FRENZY blog each publish independent commentary on Stone's report.
  3. 24 Apr 2026AOL, syndicating Popular Mechanics, publishes further coverage carrying a critique from Nikolai Slavov of Northeastern University.
  4. 20 May 2026Synthetic and Systems Biotechnology publishes Yaojun Tong's commentary situating DRT3 among a wider class of defence-associated reverse transcriptases.
  5. 16 Jun 2026Frontiers in Microbiology publishes Sarfaraz Niazi's review naming the limits on DRT3's programmability.
  6. 2 Jul 2026Molecular Cell publishes a comment by Yang, Zhang and Yang on the April paper.
  7. 28 Jul 2026Cell publishes Wang and colleagues' paper reporting the RecBCD/Gam-linked defence mechanism, from a separate group at Columbia and the University of Tokyo.
  8. 6 Aug 2026Cell publishes Figiel and Nowotny's preview of the Wang paper.

Two Readings of the Same Finding Biologists do not agree on what it means.

PositionArgument
A genuine conceptual shift
Adi Millman (MIT)
Information appears to flow from the protein's structure to a DNA sequence, which — as Stone reports it — Millman calls a meaningful shift in how the central dogma is understood.
A rigid, single-purpose machine
Nikolai Slavov (Northeastern)
Drt3b is a highly specialised structural constraint, a “stuttering machine” that produces one repeat — not a general-purpose protein-to-DNA code.
No dogma broken
Anna Meldolesi and the biologists she cites
The DNA that Drt3b makes is not integrated into the genome, so heritable information flow is unchanged and the dogma as originally stated still holds.
What both sides agree onDrt3b makes one specific repeating sequence. It is not, as things stand, a general protein-to-DNA coding mechanism.

How Reverse Transcriptase Keeps Being Repurposed Three earlier acts, and Drt3b's own.

  • Retroviruses: HIV and others use reverse transcriptase to turn an RNA genome into DNA that integrates into the host chromosome — the best-known use.
  • CRISPR: reverse transcriptase is a component of some CRISPR-linked defences, helping bacteria record viral sequences.
  • New genes: it also participates in mechanisms by which bacteria generate new genes.
  • Drt3b: it extends the line furthest yet, templating DNA on its own protein structure rather than on any nucleic acid at all.

The Defence Question, Now Partly Answered A different group finds a trigger.

Wang and colleagues at Columbia and the University of Tokyo — a separate group from the one that first described DRT3 — report that DRT3 is toxic to bacterial cells lacking RecBCD, the host's own DNA-repair and recombination complex. The phage-encoded protein Gam, which normally works by disabling RecBCD, is what triggers DRT3's abortive-infection response instead. Drt3b itself forms a hexamer, using residues next to its active site as gates that enforce the alternating addition of deoxyadenosine and deoxycytidine. Philip Kranzusch of Harvard, commenting on the original paper before this mechanism was reported, had noted that if a defence role were confirmed, DRT3 would complement other defence polymerase-like proteins that also produce nucleic acid polymers — roughly the shape the Columbia/Tokyo finding takes.

Not the Only One How many bacterial defence systems remain unexamined.

Yaojun Tong's commentary situates DRT3 within a wider, only recently recognised class of defence-associated reverse transcriptases across bacteria — DRT3 is an extreme case on that spectrum, not an isolated one. Aude Bernheim of the Institut Pasteur, discussing the original finding, said the prospect that many still-unannotated bacterial defence systems “encode exotic biochemical functions” like this one is exciting. Alex Gao himself, quoted by Stone, put the core claim plainly: “The protein itself serves as the blueprint for the DNA sequence.”

What Has Not Been Shown As of Niazi's June 2026 review.

  • Drt3b has not been engineered to produce any sequence other than its own fixed repeat.
  • It has not been validated in a mammalian system.

What to Take Away A confirmed mechanism, a live disagreement, and an early-stage technology.

A confirmed first, a disputed meaning

That a protein's own structure can template a DNA sequence is now a peer-reviewed, independently indexed finding, not merely a claim in a single news report. What it means for the central dogma remains a live disagreement among named biologists — not something this rewrite can settle, and not something it needs to.

The defence answer came from elsewhere

The RecBCD/Gam mechanism answers part of the question the original paper left open — but it comes from a different group, at Columbia and the University of Tokyo, not from the Stanford lab that first described DRT3. Whether it is the whole account of DRT3's defensive role, or one part of it, is not established by the published abstract alone.

Early days for engineering

As of the most recent review, in June 2026, Drt3b makes only its one fixed repeat and has not been shown working in a mammalian system. Whether it becomes a programmable way of writing DNA, in the way CRISPR became an editing tool, is a question the field has raised and not yet answered.

Quick notes

  1. Reverse transcriptase · Central dogma · Science, 16 April 2026

    A Way of Making DNA in Which the Protein Is the Blueprint

    A bacterial defence enzyme, Drt3b, builds DNA using its own protein’s amino-acid arrangement as the template — not RNA, and without precedent.

    DRT3 — protein-templated DNA1 / 12

  2. What happened

    The finding in four numbers

    • 2 RTDRT3 pairs a conventional Drt3a with an unconventional Drt3b
    • 2.6 Åresolution of the cryo-EM structure of the Drt3a:Drt3b:ncRNA complex
    • 6:6:6stoichiometry of that resolved complex
    • 103days from the original paper to a confirmed defence mechanism

    DRT3 — protein-templated DNA2 / 12

  3. What happened · the mechanism

    A conventional Drt3a, an unconventional Drt3b

    Alex Gao, quoted by Stone: “The protein itself serves as the blueprint for the DNA sequence.”

    DRT3

    A bacterial anti-phage defence that pairs a conventional Drt3a with an unconventional Drt3b.

    Drt3b

    Builds DNA using the arrangement of amino acids in its own active site as the template — not RNA.

    What it makes

    One fixed, repeating sequence.

    DRT3 — protein-templated DNA3 / 12

  4. What happened · the structure

    Peer-reviewed, and resolved by cryo-EM

    Deng, Lee, Armijo, Wang and Gao, Science, 16 April 2026 — peer-reviewed and PubMed-indexed (PMID 41990131).

    • 2.6 Åresolution of the cryo-EM structure of the Drt3a:Drt3b:ncRNA complex
    • 6:6:6stoichiometry of that resolved complex

    DRT3 — protein-templated DNA4 / 12

  5. The argument

    Two Readings of the Same Finding

    Biologists do not agree on what it means.

    PositionArgument
    A genuine conceptual shift
    Adi Millman (MIT)
    Information appears to flow from the protein's structure to a DNA sequence, which — as Stone reports it — Millman calls a meaningful shift in how the central dogma is understood.
    A rigid, single-purpose machine
    Nikolai Slavov (Northeastern)
    Drt3b is a highly specialised structural constraint, a “stuttering machine” that produces one repeat — not a general-purpose protein-to-DNA code.
    No dogma broken
    Anna Meldolesi and the biologists she cites
    The DNA that Drt3b makes is not integrated into the genome, so heritable information flow is unchanged and the dogma as originally stated still holds.

    DRT3 — protein-templated DNA5 / 12

  6. What others add · the defence

    The Defence Question, Now Partly Answered

    Wang and colleagues, Cell, 28 July 2026 — a separate group, at Columbia and the University of Tokyo.

    • DRT3 is toxic to bacterial cells lacking RecBCD, the host’s own recombination complex.
    • The phage-encoded protein Gam, which normally works by disabling RecBCD, is what triggers DRT3’s abortive-infection response instead.
    • Drt3b forms a hexamer, using residues next to its active site as gates that enforce the alternating addition of deoxyadenosine and deoxycytidine.

    DRT3 — protein-templated DNA6 / 12

  7. What others add

    Not the Only One

    How many bacterial defence systems remain unexamined.

    Philip Kranzusch (Harvard)

    Before the mechanism was reported: if a defence role were confirmed, DRT3 would complement other defence polymerase-like proteins that also produce nucleic acid polymers.

    Yaojun Tong

    Situates DRT3 within a wider, only recently recognised class of defence-associated reverse transcriptases across bacteria.

    Aude Bernheim (Institut Pasteur)

    The prospect that many still-unannotated bacterial defence systems “encode exotic biochemical functions” like this one is exciting.

    DRT3 — protein-templated DNA7 / 12

  8. What others add · the limits

    What Has Not Been Shown

    As of Niazi's June 2026 review.

    • Drt3b has not been engineered to produce any sequence other than its own fixed repeat.
    • It has not been validated in a mammalian system.

    Early days for engineering

    Whether it becomes a programmable way of writing DNA, in the way CRISPR became an editing tool, is a question the field has raised and not yet answered.

    DRT3 — protein-templated DNA8 / 12

  9. What happened · the evidence

    How Firmly Each Part Stands

    How firmWhatWho says so
    ConfirmedThe Drt3a/Drt3b structure and mechanism, by cryo-EM to 2.6 ÅScience, peer-reviewed, PMID 41990131
    ConfirmedDRT3 is cytotoxic without RecBCD; Gam triggers its abortive-infection responseCell, peer-reviewed, PMID 42520802
    ConfirmedStone’s news article in Science, 16 April 2026EBSCO and Crossref records, both read directly; its own page returned HTTP 403
    Confirmed, but not verifiable hereThe quotations from Gao, Millman, Kranzusch and BernheimGao’s by ScienceAlert and AOL/Popular Mechanics; the other three only by search extracts

    DRT3 — protein-templated DNA9 / 12

  10. Timeline · April 2026

    Every Publication With a Date

    Ten papers and reports, over sixteen weeks

    1. 16 Apr 2026Science publishes Deng, Lee, Armijo, Wang and Gao's paper on DRT3, and Richard Stone's accompanying news article.
    2. 21 Apr 2026ScienceAlert and the CRISPeR FRENZY blog each publish independent commentary on Stone's report.
    3. 24 Apr 2026AOL, syndicating Popular Mechanics, publishes further coverage carrying a critique from Nikolai Slavov of Northeastern University.

    DRT3 — protein-templated DNA10 / 12

  11. Timeline

    Five follow-ups, May to August 2026

    1. 20 May 2026Synthetic and Systems Biotechnology publishes Yaojun Tong's commentary situating DRT3 among a wider class of defence-associated reverse transcriptases.
    2. 16 Jun 2026Frontiers in Microbiology publishes Sarfaraz Niazi's review naming the limits on DRT3's programmability.
    3. 2 Jul 2026Molecular Cell publishes a comment by Yang, Zhang and Yang on the April paper.
    4. 28 Jul 2026Cell publishes Wang and colleagues' paper reporting the RecBCD/Gam-linked defence mechanism, from a separate group at Columbia and the University of Tokyo.
    5. 6 Aug 2026Cell publishes Figiel and Nowotny's preview of the Wang paper.

    DRT3 — protein-templated DNA11 / 12

  12. Conclusion

    What to Take Away

    A confirmed mechanism, a live disagreement, and an early-stage technology.

    A confirmed first, a disputed meaning

    That a protein’s own structure can template a DNA sequence is a peer-reviewed, independently indexed finding. What it means for the central dogma remains a live disagreement among named biologists.

    The defence answer came from elsewhere

    The RecBCD/Gam mechanism answers part of the question, from a different group, not the Stanford lab. Whether it is the whole account is not established by the published abstract alone.

    Early days for engineering

    As of the June 2026 review, Drt3b makes only its one fixed repeat and has not been shown working in a mammalian system.

    DRT3 — protein-templated DNA12 / 12

  • Deng, Lee, Armijo, Wang and Gao, Science, 16 Apr 2026, DOI 10.1126/science.aed1656 (PMID 41990131)
  • Richard Stone, Science news, 16 Apr 2026 — confirmed via EBSCO and Crossref records
  • the page itself returned HTTP 403 in this session
  • Nield, ScienceAlert, 21 Apr 2026
  • Meldolesi, CRISPeR FRENZY, 21 Apr 2026
  • Orf, AOL/Popular Mechanics, 24 Apr 2026
  • Tong, Synthetic and Systems Biotechnology, 20 May 2026 (PMID 42212300)
  • Niazi, Frontiers in Microbiology, 16 Jun 2026 (PMID 42382356)
  • Yang, Zhang and Yang, Molecular Cell, 2 Jul 2026 (PMID 42392043)
  • Wang et al., Cell, 28 Jul 2026 (PMID 42520802)
  • Figiel and Nowotny, Cell, 6 Aug 2026 (PMID 42561911)

You are reading v0002, published 2026-04-22. It has been superseded — the current version is v0003.

Versions

This document is rewritten when what it says has to change. Every version stays published at its own address.

  1. v0003 current
  2. v0002 superseded
  3. v0001 superseded

The current version is also at latest/.